Keros Therapeutics, Inc.

NASDAQ (USD): Keros Therapeutics, Inc. (KROS)

Last Price

62.58

Today's Change

+2.63 (4.38%)

Day's Change

59.50 - 62.93

Trading Volume

317,302

Financial

Reported Currency in USD
Show?
Last 10 FY Result (Thousand)
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 151 0 20,100 0 10,000 10,000 -56.74%
PBT -152,992 -104,679 -56,733 -45,533 -12,336 -1,078 169.26%
Tax -206 1 2,011 -172 8 257 -
NP -152,992 -104,680 -58,744 -45,361 -12,344 -1,335 157.99%
Tax Rate - - - - - - -
Total Cost 153,143 104,680 78,844 45,361 22,344 11,335 68.27%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -101,319.21 0.00 -292.26 0.00 -123.44 -13.35 496.50%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -5.20 -4.15 -2.52 -2.93 -1.39 -0.15 103.14%
EPS Diluted -5.20 -4.15 -2.52 -2.93 -1.39 -0.15 103.14%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment